CBIC Circular 2026: Fast-Track AEO T1 Approval for Pharma Exporters

## Key points To bolster India's position as the 'Pharmacy of the World,' the Central Board of Indirect Taxes and Customs (CBIC) has issued **Circular No. 18/2026-Customs dated 2026-08-10**. This circular introduces a fast-track compliance track for pharmaceutical manufacturers seeking **Authorized Economic Operator (AEO) T1** status. The revised norms waive several manual document requirements, relying instead on drug license validations. ## What this means for exporters Pharmaceutical units can now secure AEO India T1 status within 15 days of application. The primary benefit includes a significant reduction in the bank guarantee required for **Advance Authorization** and **EPCG** schemes, alongside priority clearance at Nhavasheva and other major ports. This move reduces transaction costs and improves liquidity for SME manufacturers who can now bypass intensive physical examinations of cargo. **Who should act now:** Pharmaceutical manufacturers with a clean track record of at least two years should apply immediately to leverage the 'Green Channel' benefits and duty deferment facilities. Need help with AEO documentation? **We Design For You** provides end-to-end consultancy for AEO India certification and Customs compliance to ensure your shipments move without delay.